Claret Asset Management Corp Taro Pharmaceutical Industries LTD Transaction History

Claret Asset Management Corp

$611 Million
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$28.74 - $39.9 $3,075 - $4,269	-107 Reduced 1.48%	7,119 $213,000
Q2 2022 Jul 28, 2022	SELL	$35.0 - $43.59 $1,855 - $2,310	-53 Reduced 0.73%	7,226 $261,000
Q1 2022 Apr 04, 2022	SELL	$43.12 - $50.3 $17,981 - $20,975	-417 Reduced 5.42%	7,279 $315,000
Q4 2021 Feb 07, 2022	SELL	$47.6 - $65.0 $78,064 - $106,600	-1,640 Reduced 17.57%	7,696 $386,000
Q3 2021 Dec 02, 2021	SELL	$62.34 - $73.38 $126,861 - $149,328	-2,035 Reduced 17.9%	9,336 $594,000
Q2 2021 Aug 09, 2021	SELL	$70.26 - $76.64 $276,613 - $301,731	-3,937 Reduced 25.72%	11,371 $818,000
Q1 2021 May 04, 2021	SELL	$70.48 - $79.95 $92,117 - $104,494	-1,307 Reduced 7.87%	15,308 $1.13 Million
Q4 2020 Feb 02, 2021	SELL	$54.4 - $73.42 $1.18 Million - $1.6 Million	-21,767 Reduced 56.71%	16,615 $1.22 Million
Q3 2020 Oct 29, 2020	SELL	$54.41 - $68.2 $1.05 Million - $1.32 Million	-19,355 Reduced 33.52%	38,382 $2.11 Million
Q2 2020 Aug 06, 2020	SELL	$61.66 - $70.16 $1.07 Million - $1.22 Million	-17,354 Reduced 23.11%	57,737 $3.84 Million
Q1 2020 Apr 06, 2020	SELL	$59.35 - $88.73 $435,747 - $651,455	-7,342 Reduced 8.91%	75,091 $4.6 Million
Q4 2019 Jan 07, 2020	SELL	$74.18 - $97.92 $299,761 - $395,694	-4,041 Reduced 4.67%	82,433 $7.25 Million
Q3 2019 Oct 11, 2019	SELL	$75.36 - $86.57 $455,249 - $522,969	-6,041 Reduced 6.53%	86,474 $6.52 Million
Q2 2019 Jul 24, 2019	SELL	$83.92 - $108.88 $127,222 - $165,062	-1,516 Reduced 1.61%	92,515 $7.9 Million
Q1 2019 Apr 29, 2019	SELL	$85.97 - $108.09 $24,673 - $31,021	-287 Reduced 0.3%	94,031 $10.2 Million
Q4 2018 Feb 07, 2019	BUY	$78.25 - $107.92 $4,460 - $6,151	57 Added 0.06%	94,318 $7.98 Million
Q3 2018 Oct 30, 2018	BUY	$97.82 - $116.09 $1,956 - $2,321	20 Added 0.02%	94,261 $9.27 Million
Q2 2018 Aug 13, 2018	BUY	$97.62 - $120.59 $170,737 - $210,911	1,749 Added 1.89%	94,241 $10.9 Million
Q1 2018 May 08, 2018	SELL	$95.91 - $107.26 $124,683 - $139,438	-1,300 Reduced 1.39%	92,492 $9.13 Million
Q4 2017 Mar 27, 2018	BUY	$104.5 - $126.38 $9.8 Million - $11.9 Million	93,792	93,792 $9.82 Million

Others Institutions Holding TARO

# of Institutions

Shares Held

17K

Call Options Held

Put Options Held

View Full List

About TARO PHARMACEUTICAL INDUSTRIES LTD

Ticker TARO
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 37,584,600
Description
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...

More about TARO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Claret Asset Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Claret Asset Management Corp with notifications on news.

Account